161 related articles for article (PubMed ID: 31260717)
1. Maintenance and enhancement of human peripheral blood mobilized stem/progenitor cell engraftment after ex vivo culture via an HDACi/SALL4 axis (3465).
Tatetsu H; Armant M; Wang F; Gao C; Ueno S; Tian X; Federation A; Qi J; Bradner J; Tenen DG; Chai L
Exp Hematol; 2019 Jul; 75():53-63.e11. PubMed ID: 31260717
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers.
Saraf S; Araki H; Petro B; Park Y; Taioli S; Yoshinaga KG; Koca E; Rondelli D; Mahmud N
Transfusion; 2015 Apr; 55(4):864-74. PubMed ID: 25363624
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
[TBL] [Abstract][Full Text] [Related]
4. Advances in umbilical cord blood stem cell expansion and clinical translation.
Pineault N; Abu-Khader A
Exp Hematol; 2015 Jul; 43(7):498-513. PubMed ID: 25970610
[TBL] [Abstract][Full Text] [Related]
5. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents.
Araki H; Mahmud N; Milhem M; Nunez R; Xu M; Beam CA; Hoffman R
Exp Hematol; 2006 Feb; 34(2):140-9. PubMed ID: 16459182
[TBL] [Abstract][Full Text] [Related]
6. Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells.
Arulmozhivarman G; Kräter M; Wobus M; Friedrichs J; Bejestani EP; Müller K; Lambert K; Alexopoulou D; Dahl A; Stöter M; Bickle M; Shayegi N; Hampe J; Stölzel F; Brand M; von Bonin M; Bornhäuser M
Sci Rep; 2017 Sep; 7(1):12084. PubMed ID: 28935977
[TBL] [Abstract][Full Text] [Related]
7. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
Tanavde VM; Malehorn MT; Lumkul R; Gao Z; Wingard J; Garrett ES; Civin CI
Exp Hematol; 2002 Jul; 30(7):816-23. PubMed ID: 12135681
[TBL] [Abstract][Full Text] [Related]
8. Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues.
Araki H; Baluchamy S; Yoshinaga K; Petro B; Petiwala S; Parajuli R; Milhem M; Lavelle D; DeSimone J; Mahmud N
Exp Hematol; 2009 Sep; 37(9):1084-95. PubMed ID: 19501128
[TBL] [Abstract][Full Text] [Related]
9. Endothelial progenitor cells promote efficient ex vivo expansion of cord blood-derived hematopoietic stem/progenitor cells.
Qu Q; Liu L; Chen G; Xu Y; Wu X; Wu D
Cytotherapy; 2016 Mar; 18(3):452-64. PubMed ID: 26857234
[TBL] [Abstract][Full Text] [Related]
10. Short-Term exposure of umbilical cord blood CD34+ cells to human platelet lysate and cytokines enhances engraftment.
Rhéaume MÈ; Rouleau P; Tremblay T; Paré I; Loubaki L
Transfusion; 2020 Oct; 60(10):2348-2358. PubMed ID: 32757244
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
Lam YM; Chan YF; Chan LC; Ng RK
Int J Hematol; 2017 Jan; 105(1):37-43. PubMed ID: 27531147
[TBL] [Abstract][Full Text] [Related]
12. Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34
Arcangeli ML; Brault P; Bourhis JH; Kuhnowskie F; Henry E; Barroca V; Koscielny S; Pflumio F; Amsellem S
Exp Hematol; 2020 Jun; 86():15-20.e2. PubMed ID: 32450206
[TBL] [Abstract][Full Text] [Related]
13. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
[TBL] [Abstract][Full Text] [Related]
14. Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokines.
Young JC; Lin K; Travis M; Hansteen G; Abitorabi A; Sirenko O; Murray L; Hill B
Cytotherapy; 2001; 3(4):307-20. PubMed ID: 12171719
[TBL] [Abstract][Full Text] [Related]
15. Ex Vivo Expansion of CD34
Bari S; Zhong Q; Fan X; Poon Z; Lim AST; Lim TH; Dighe N; Li S; Chiu GNC; Chai CLL; Hwang WYK
Stem Cells Transl Med; 2018 May; 7(5):376-393. PubMed ID: 29392885
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic reprogramming induces the expansion of cord blood stem cells.
Chaurasia P; Gajzer DC; Schaniel C; D'Souza S; Hoffman R
J Clin Invest; 2014 Jun; 124(6):2378-95. PubMed ID: 24762436
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors.
Gajzer D; Ross J; Winder L; Navada S; Zhang W; Silverman L; Chaurasia P
Vox Sang; 2016 Jan; 110(1):79-89. PubMed ID: 26084882
[TBL] [Abstract][Full Text] [Related]
18. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
[TBL] [Abstract][Full Text] [Related]
19. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
20. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.
Piacibello W; Sanavio F; Severino A; Danè A; Gammaitoni L; Fagioli F; Perissinotto E; Cavalloni G; Kollet O; Lapidot T; Aglietta M
Blood; 1999 Jun; 93(11):3736-49. PubMed ID: 10339480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
